Font Size: a A A
Keyword [Heart failure with preserved ejection fraction]
Result: 141 - 160 | Page: 8 of 9
141. Effect Of Sacubitril/valsartan On Heart Failure With Preserved Ejection Fraction
142. Single-cell Sequencing Of Heart Failure With Preserved Ejection Fraction
143. Efficacy And Safety Of Sacubitril/Valsartan In The Treatment Of Heart Failure With Preserved Ejection Fraction: A Meta-analysis
144. Efficacy Of Sacubitril/valsartan In Patients With Heart Failure With Preserved Ejection Fraction And Chronic Kidney Disease
145. Comparison Of Prognostic Effects Of Rhythm Control And Heart Rate Control The Rapies In Heart Failure With Preserved Ejection Fraction Patients Complicated With Atrial Fibrillation
146. Effect Of Dapagliflozin On Cardiac Function In Patients With Type 2 Diabetes Mellitus And Heart Failure With Preserved Ejection Fraction
147. Study On The Mechanism Of Calcium Regulatory Protein Involving In NLRP3 Inflammasome Activation In Heart Failure With Preserved Ejection Fraction Induced By Hypertension
148. A Study On The Identification Of Heart Failure With Preserved Ejection Fraction Based On Heart Sound And Its Multifractal Characteristics Analysis
149. Intervention Studies Of Yangxinshi On Exercise Intensity And Quality Of Life On Heart Failure With Preserved Ejection Fraction
150. The Relationship Between Pulse Pressure And Left Ventricular Hypertrophy And Heart Failure With Preserved Ejection Fraction In Patients With Essential Hypertension
151. Clinical Observation Of Yi Qi Sheng Jiang Recipe On Patients With Ejection Fraction Retention Heart Failure
152. The Relationship Between D-dimer And Clinical Outcomes In HFpEF And Sinus Rhythm During Hospitalization
153. Clinical Characteristics And Prognosis Analysis Among Patients Of Heart Failure With Preserved Ejection Fraction Combined With Type2 Diabetes Mellitus
154. Evaluation Of The Effect Of Radiofrequency Ablation On The Function Of The Left Ventricle In Patients With HFpEF -AF By 2D-STI
155. Protective Effect Of Catheter Ablation On Atrial Fibrillation With Ejection Fraction Preserved Heart Failure
156. Analysis Of The Efficacy Of Tolvaptan In The Treatment Of Heart Failure With Preserved Ejection Fraction
157. The Study Of The Relationship Between Urinary Albumin Excretion Rate And Heart Failure With Preserved Ejection Fraction
158. Correlation Of Heart Rate Variability And Cardiac Structure And Function In Heart Failure With Preserved Ejection Fraction
159. Correlation Of Pulse Pressure,pulse Pressure Index And Cardiac Structure And Function In Heart Failure With Preserved Ejection Fraction
160. The C2HEST Score Assesses The Predictive Value Of The Risk Of Atrial Fibrillation And Prognosis In Patients With HFpEF
  <<First  <Prev  Next>  Last>>  Jump to